Innovating Works

CHDR

Desconocido
Inno4Vac: Innovations to accelerate vaccine development and manufacture STICHTING CENTRE FOR HUMAN DRUG RESEARCH participó en un H2020: H2020-JTI-IMI2-2020-20-two-stage Inno4Vac proposes an ambitious programme that will harness the latest advances in immunology, disease modelling, and modelling for tackling...
2021-07-19 - 2027-02-28 | Financiado
INCENTIVE: Indo European Consortium for Next Generation Influenza Vaccine Innovation STICHTING CENTRE FOR HUMAN DRUG RESEARCH participó en un H2020: H2020-SC1-BHC-2018-2020 The highly integrated INCENTIVE consortium represents true partnership between Indian and European/US groups that addresses the global healt...
2019-12-13 - 2025-07-31 | Financiado
QSPainRelief: Effective combinational treatment of chronic pain in individual patients by an innovative quantitat... STICHTING CENTRE FOR HUMAN DRUG RESEARCH participó en un H2020: H2020-SC1-BHC-2018-2020 Chronic pain is a complex disease suffered by about 20% of Europeans. Up to 60% of these patients do not experience adequate pain relief fro...
2019-12-13 - 2025-06-30 | Financiado
TAcTIC: TArgeTed molecular Imaging and surgery for gastro intestinal Cancer STICHTING CENTRE FOR HUMAN DRUG RESEARCH participó en un H2020: ERC-2018-PoC The treatment for cancer patients is shifting from population-based treatment to the more precise personalized medicine. Tumor-specific mole...
2019-07-11 - 2021-01-31 | Financiado
VIA: Vaccination In Atherosclerosis STICHTING CENTRE FOR HUMAN DRUG RESEARCH participó en un FP7: "Cardiovascular disease (CVD) is still a leading cause of death in the European Union (EU) accounting for nearly half of all deaths in Europ...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.